Back to Companies
NOVAVAX INC
NVAXNasdaqCIK: 0001000694
Over the 27 most recent insider filings, NOVAVAX INC (NVAX) has seen activity from 14 distinct insiders — no open-market buying or selling. Jacobs John C (President and CEO, Director) is the most active by dollar volume, and the single largest transaction was $5.4M by Jacobs John C. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$16.0M
Purchases
$0
Sales
$0
Unique Insiders
14
Recent Insider Trades
27 loaded
| Jun 23 | NVAX NOVAVAX INC | Shiver John W. | Director | Award | $194.2K |
| Jun 23 | NVAX NOVAVAX INC | Newton Charles W. | Director | Award | $194.2K |
| Jun 23 | NVAX NOVAVAX INC | MCGLYNN MARGARET G | Director | Exercise | $194.2K |
| Jun 23 | NVAX NOVAVAX INC | Rodgers Richard J | Director | Exercise | $194.2K |
| Jun 23 | NVAX NOVAVAX INC | Alton Gregg H | Director | Exercise | $194.2K |
| Jun 23 | NVAX NOVAVAX INC | MOTT DAVID M | Director | Exercise | $194.2K |
| Jun 23 | NVAX NOVAVAX INC | DOUGLAS RICHARD | Director | Exercise | $194.2K |
| Jun 23 | NVAX NOVAVAX INC | King Rachel K. | Director | Exercise | $194.2K |
| Apr 16 | NVAX NOVAVAX INC | Walker Robert Edward | EVP, R&D | Award | $841.8K |
| Apr 16 | NVAX NOVAVAX INC | Walker Robert Edward | EVP, R&D | Other | $0 |
| Mar 9 | NVAX NOVAVAX INC | Kelly James Patrick | EVP, CFO and Treasurer | Exercise | $58.9K |
| Mar 5 | NVAX NOVAVAX INC | O'Hara Elaine | EVP, Chief Strategy Officer | Exercise | $212.9K |
| Mar 5 | NVAX NOVAVAX INC | Jacobs John C | President and CEO, Director | Exercise | $657.5K |
| Mar 5 | NVAX NOVAVAX INC | Casey Mark J | EVP, Chief Legal Officer | Exercise | $108.0K |
| Mar 5 | NVAX NOVAVAX INC | Kelly James Patrick | EVP, CFO and Treasurer | Exercise | $197.9K |
| Mar 9 | NVAX NOVAVAX INC | Jacobs John C | President and CEO, Director | Award | $0 |
| Mar 9 | NVAX NOVAVAX INC | O'Hara Elaine | EVP, Chief Strategy Officer | Award | $0 |
| Mar 9 | NVAX NOVAVAX INC | Casey Mark J | EVP, Chief Legal Officer | Award | $0 |
| Mar 5 | NVAX NOVAVAX INC | Draghia-Akli Ruxandra | EVP, Research & Development | Exercise | $1.4M |
| Mar 9 | NVAX NOVAVAX INC | Draghia-Akli Ruxandra | EVP, Research & Development | Award | $0 |
| Mar 9 | NVAX NOVAVAX INC | Kelly James Patrick | EVP, CFO and Treasurer | Award | $0 |
| Mar 3 | NVAX NOVAVAX INC | O'Hara Elaine | EVP, Chief Strategy Officer | Exercise | $1.8M |
| Mar 3 | NVAX NOVAVAX INC | Kelly James Patrick | EVP, CFO and Treasurer | Exercise | $2.1M |
| Mar 3 | NVAX NOVAVAX INC | Jacobs John C | President and CEO, Director | Exercise | $5.4M |
| Mar 3 | NVAX NOVAVAX INC | Casey Mark J | EVP, Chief Legal Officer | Exercise | $1.4M |
| Jan 26 | NVAX NOVAVAX INC | Jacobs John C | President and CEO, Director | Exercise | $358.8K |
| Nov 13 | NVAX NOVAVAX INC | Draghia-Akli Ruxandra | Section 16 | Exercise | $44.8K |
27 filings